Your browser doesn't support javascript.
loading
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder.
Santoro, Jonathan D; Spinazzi, Noemi A; Filipink, Robyn A; Hayati-Rezvan, Panteha; Kammeyer, Ryan; Patel, Lina; Sannar, Elise A; Dwyer, Luke; Banerjee, Abhik K; Khoshnood, Mellad; Jafarpour, Saba; Boyd, Natalie K; Partridge, Rebecca; Gombolay, Grace Y; Christy, Alison L; Real de Asua, Diego; Del Carmen Ortega, Maria; Manning, Melanie A; Van Mater, Heather; Worley, Gordan; Franklin, Cathy; Stanley, Maria A; Brown, Ruth; Capone, George T; Quinn, Eileen A; Rafii, Michael S.
Affiliation
  • Santoro JD; Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA, USA. santoroj@usc.edu.
  • Spinazzi NA; Department of Neurology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. santoroj@usc.edu.
  • Filipink RA; Department of Pediatrics, Benioff Children's Hospital, University of California San Francisco, San Francisco, CA, USA.
  • Hayati-Rezvan P; Division of Child Neurology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
  • Kammeyer R; Division of Research on Children, Youth and Families, Keck School of Medicine of USC, Los Angeles, CA, USA.
  • Patel L; Department of Neurology, Children's Hospital of Colorado, Aurora, CO, USA.
  • Sannar EA; Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA.
  • Dwyer L; Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA.
  • Banerjee AK; Department of Psychiatry, University of Utah, Salt Lake City, UT, USA.
  • Khoshnood M; Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Jafarpour S; Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Boyd NK; Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Partridge R; Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Gombolay GY; Virginia Mason Health System, Issaquah, WA, USA.
  • Christy AL; Department of Pediatrics, Division of Neurology Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • Real de Asua D; Providence Health System, Portland, OR, USA.
  • Del Carmen Ortega M; Adult Down Syndrome Outpatient Clinic, Department of Internal Medicine, Fundación de Investigación Biomédica, Hospital Universitario de La Princesa, Madrid, Spain.
  • Manning MA; Department of Psychiatry, Clinica Universidad de Navarra, Madrid, Spain.
  • Van Mater H; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Worley G; Division of Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
  • Franklin C; Division of Pediatric Neurology and Developmental Medicine, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
  • Stanley MA; Queensland Center for Intellectual and Developmental Disability, Mater Research Institute, The University of Queensland, South Brisbane, QLD, Australia.
  • Brown R; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Capone GT; Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.
  • Quinn EA; Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Rafii MS; Department of Pediatrics, University of Toledo College of Medicine and Life Science, Toledo, OH, USA.
Transl Psychiatry ; 13(1): 276, 2023 08 08.
Article in En | MEDLINE | ID: mdl-37553347
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Down Syndrome Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transl Psychiatry Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Down Syndrome Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transl Psychiatry Year: 2023 Type: Article Affiliation country: United States